Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Imaging Services

 

Grundium acquires Visiopharm

Grundium, a Finland-based digital pathology imaging company backed by US private equity firm EW Healthcare Partners, has acquired Denmark-based AI precision pathology software provider Visiopharm. The deal aims to create an integrated digital pathology platform combining imaging and AI-driven diagnostics.

HBI 2026: AI as a value creation lever; Case studies from diagnostics

Implementation of AI is more advanced in diagnostic imaging than any other part of healthcare. Two imaging providers presented case studies to illustrate how it is being used and providing immense benefits at HBI’s 2026 conference, in a session entitled ‘AI as a value creation lever: Case studies from diagnostics’.

Delivering value through an integrated healthcare service platform — Interview with David Rolfe, Group CEO, Ergéa

HBI spoke with David Rolfe, the recently appointed Group CEO of Ergéa, a pan-European provider of Managed Equipment Services (MES) and clinical outsourcing. The company works with both public and private healthcare systems across diagnostics and oncology. In this interview, we discuss Ergéa’s growth plans, opportunities in the European healthcare market, and the key trends shaping the sector.

Simplified IT and sales processes key to accelerating AI adoption in imaging — DeepHeath’s Niccolo Stefani

US-based outpatient diagnostic imaging services provider RadNet has recently acquired French radiology AI company Gleamer in an all-cash transaction valued at €230 million (~$270 million). HBI spoke to Niccolo Stefani, Business Leader Population Health & Clinical AI, RadNet DeepHealth, about what this acquisition means for the AI platform and the overall adoption of AI in imaging.

2026 will see modest growth and selective mega deals — Interview with Matthew Edwards, Osborne Clarke

Healthcare and life sciences deal activity is expected to pick up in 2026, following trends seen in 2025 when the market remained steady despite regulatory challenges, according to a recent report from global law firm Osborne Clarke. HBI spoke to Matthew Edwards, Partner at Osborne Clarke, to explore these developments and what they could mean for healthcare and life sciences transactions in 2026.

Teleradiology company Medica buys Axon

Medica, the UK’s largest teleradiology company, has bought one of its smaller competitors, Axon Diagnostics. HBI caught up with Andrew Cannon, Medica’s CEO, to discuss the acquisition and Medica’s plans for the future.

Find Us